Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and ...
Philip Morris International Inc. closed $12.75 below its 52-week high ($134.15), which the company reached on October 31st.
Philip Morris was fined $1.2 million over the weekend ... The cautionary example here though is Juul, the high strength e-cigarette brand accused in multiple lawsuits of targeting underage users ...
Philip Morris outperformed the S&P 500 in 2024 ... ZYN is now available in 30 markets, and it has become the largest smoke-free brand in the U.S. ZYN’s shipment volume has reached 149.1 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback